Evidence map›Paper›PMID 35511226›Full record

ArticleJournal of medical Internet research2022

A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study.

Sheila Dunn, Sarah Munro, Courtney Devane, Edith Guilbert, Dahn Jeong, Eleni Stroulia, Judith A Soon, Wendy V Norman

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Sheila DunnDepartment of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-2284-1364
Sarah MunroDepartment of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-3884-6592
Courtney DevaneSchool of Nursing, Faculty of Applied Science, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-9729-2438
Edith GuilbertDepartment of Obstetrics, Gynecology and Reproduction, Laval University, Quebec City, QC, Canada.ORCID 0000-0001-7764-9076
Dahn JeongSchool of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0003-1782-5669
Eleni StrouliaDepartment of Computer Science, Faculty of Science, University of Alberta, Edmonton, AB, Canada.ORCID 0000-0002-8784-8236
Judith A SoonContraception and Abortion Research Team, Women's Health Research Institute, Provincial Health Services Authority, Vancouver, BC, Canada.ORCID 0000-0002-5274-3223
Wendy V NormanDepartment of Family Practice, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0003-4340-7882
University of British Columbia · CAProvincial Health Services Authority · CAUniversité Laval · CAUniversity of Alberta · CAUniversity of Toronto · CA

Funding

CIHR CPP-329455-107837CIHR PHE148161
6 · The paper itself

Abstract

backgroundVirtual communities of practice (VCoPs) have been used to support innovation and quality in clinical care. The drug mifepristone was introduced in Canada in 2017 for medical abortion. We created a VCoP to support implementation of mifepristone abortion practice across Canada.

objectiveThe aim of this study was to describe the development and use of the Canadian Abortion Providers Support-Communauté de pratique canadienne sur l'avortement (CAPS-CPCA) VCoP and explore physicians' experience with CAPS-CPCA and their views on its value in supporting implementation.

methodsThis was a mixed methods intrinsic case study of Canadian health care providers' use and physicians' perceptions of the CAPS-CPCA VCoP during the first 2 years of a novel practice. We sampled both physicians who joined the CAPS-CPCA VCoP and those who were interested in providing the novel practice but did not join the VCoP. We designed the VCoP features to address known and discovered barriers to implementation of medication abortion in primary care. Our secure web-based platform allowed asynchronous access to information, practice resources, clinical support, discussion forums, and email notices. We collected data from the platform and through surveys of physician members as well as interviews with physician members and nonmembers. We analyzed descriptive statistics for website metrics, physicians' characteristics and practices, and their use of the VCoP. We used qualitative methods to explore the physicians' experiences and perceptions of the VCoP.

resultsFrom January 1, 2017, to June 30, 2019, a total of 430 physicians representing all provinces and territories in Canada joined the VCoP and 222 (51.6%) completed a baseline survey. Of these 222 respondents, 156 (70.3%) were family physicians, 170 (80.2%) were women, and 78 (35.1%) had no prior abortion experience. In a survey conducted 12 months after baseline, 77.9% (120/154) of the respondents stated that they had provided mifepristone abortion and 33.9% (43/127) said the VCoP had been important or very important. Logging in to the site was burdensome for some, but members valued downloadable resources such as patient information sheets, consent forms, and clinical checklists. They found email announcements helpful for keeping up to date with changing regulations. Few asked clinical questions to the VCoP experts, but physicians felt that this feature was important for isolated or rural providers. Information collected through member polls about health system barriers to implementation was used in the project's knowledge translation activities with policy makers to mitigate these barriers.

conclusionsA VCoP developed to address known and discovered barriers to uptake of a novel medication abortion method engaged physicians from across Canada and supported some, including those with no prior abortion experience, to implement this practice. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.1136/bmjopen-2018-028443.

Indexed as

Abortion, InducedMifepristoneCanadaFemaleHumansMalePhysicians, FamilyPregnancySurveys and QuestionnairesMifepristoneabortioncommunity of practicediffusion of innovationlearning communitymifepristonevirtual community of practice

Identifiers

PMID35511226
PMCPMC9121225
OpenAlexW4229001020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.